4 Firms Lead French Biotech Genfit's Estimated $132M IPO
French biotechnology company Genfit SA on Thursday launched plans for an estimated $132 million United States initial public offering, guided by four law firms, that will help fund therapies treating potentially deadly...To view the full article, register now.
Already a subscriber? Click here to view full article